Teneblu Tablet
By Teneblu
Rx
15 Tablet in a Strip

Composition
Teneligliptin(20mg)

Manufacturer - Blue Cross Laboratories Ltd
Peninsula Chambers, Peninsula Corporate Park, G.K Marg, Lower Parel (West), Mumbai - 400013, Maharashtra, INDIA.

Expires on or after
August, 2026

liver
When it comes to the safety of Teneblu Tablet in relation to liver issues, it is important to note that this medication is considered safe for use in patients with liver disease. It is not usually necessary to adjust the dosage of Teneblu Tablet specifically for liver issues. However, it is crucial to highlight that there is no clear clinical evidence supporting its use in patients with severe kidney impairment. Therefore, if you have a history or evidence of any liver-related diseases, it is highly advisable to consult your doctor before starting to take Teneblu Tablet to ensure its suitability for your condition.

kidney
Teneblu Tablet can be used safely in patients with kidney disease without needing a dose adjustment. However, if you have a history of kidney-related issues, it is advised to consult your doctor before taking this medication.

alcohol
It is unsafe to drink alcohol while taking Teneblu Tablet. It is recommended to avoid alcohol when using this medication.

driving
When your blood sugar is too low or too high, it might affect your ability to drive. If you have symptoms, avoid driving. Also, refrain from driving if you feel dizzy.

pregnancy
Teneblu Tablet is not recommended during pregnancy as limited studies have shown potential harm to the developing baby. Your doctor will evaluate the benefits and risks before prescribing this medication. Please consult your doctor before taking Teneblu Tablet during pregnancy.

breastfeeding
Teneblu Tablet may not be safe while breastfeeding. Limited data indicates possible transfer to breastmilk, which could harm the baby. Consult your doctor before using Teneblu Tablet.
Habit Forming | No |
Chemical Class | Alpha amino acid amides |
Therapeutic Class | ANTI DIABETIC |
Action Class | DPP-4 inhibitors |
₹71
Inclusive of all taxes
Content verified by

Dr. Archana Prabhakar
MBBS, M.Med (Family Medicine)
Last update on 18-Nov-2024